| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 04/14/2009 | US7517901 p38 MAP kinase inhibitors and methods for using the same |
| 04/14/2009 | US7517900 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/14/2009 | US7517877 5-substituted-alkylaminopyrazole derivatives as pesticides |
| 04/09/2009 | WO2009044937A1 Method for producing pyrazolinone derivative |
| 04/09/2009 | WO2009022311A3 1,2-diamido-ethylene derivatives as orexin antagonists |
| 04/09/2009 | WO2009016218A3 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 04/09/2009 | WO2008022777A8 Process for preparing 3-dihalomethylpyrazole-4-carboxylic acid derivatives |
| 04/09/2009 | US20090093637 Synthesis of 1,3,4-Trisubstituted and 1,3,4,5-Tetrasubstituted Pyrazoles |
| 04/09/2009 | US20090093532 Polymorphs and amorphous forms of 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1h-pyrazole-3-carbonitrile |
| 04/09/2009 | US20090093484 Novel compounds, their preparation and use |
| 04/09/2009 | US20090093464 Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor |
| 04/09/2009 | US20090093444 Cathepsin Cysteine Protease Inhibitors |
| 04/09/2009 | CA2698928A1 Compounds and methods for treating zinc matrix metalloprotease dependent diseases |
| 04/08/2009 | EP2045244A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 04/08/2009 | EP2044032A2 Novel inhibitors of hepatitis c virus replication |
| 04/08/2009 | EP2044031A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 04/08/2009 | EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 04/08/2009 | EP2044006A1 Insecticidal compounds |
| 04/08/2009 | EP2043634A2 Substituted pyrazoles as ghrelin receptor antagonists |
| 04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/08/2009 | CN101405271A Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/08/2009 | CN101405270A Pyrazoles as 11-beta-HSD-1 |
| 04/08/2009 | CN101405259A Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475799C Merocyanine derivatives for cosmetic use |
| 04/08/2009 | CN100475792C Novel gamma-secretase inhibitors |
| 04/07/2009 | US7514570 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (GnRH) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 04/07/2009 | US7514561 Pesticidal 5-(acylamino) pyrazole derivatives |
| 04/07/2009 | US7514465 selective inhibitor of protease activated receptor (PAR)-4-dependent activation; inhibits low thrombin-induced Ca++ signal and thromboxane production; inhibit vascular endothelial growth factor induced cell proliferation, migration, tube formation in human umbilial vein endothelial cells; antitumor agent |
| 04/07/2009 | US7514464 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; parasiticides; fleas; Extended duration of action for at least 28 days |
| 04/07/2009 | US7514463 Lonidamine analogues and their use in male contraception and cancer treatment |
| 04/07/2009 | US7514457 Substituted aryloxymethyl bicyclicmethyl acetamide compounds |
| 04/07/2009 | US7514428 Pesticidal 1-aryl-3-amidoxime-pyrazole derivatives |
| 04/07/2009 | CA2381243C 1-cycloalkylpyrazoyl-benzoyl derivatives |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009041470A1 Method for producing hydroxylated adamantane using cytochrome p450 |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | WO2009021747A3 Treatment of duchenne muscular dystrophy |
| 04/02/2009 | US20090088576 Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds |
| 04/02/2009 | US20090088463 Pyrazoles Useful in the Treatment of Inflammation |
| 04/02/2009 | CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/01/2009 | EP2041089A1 Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/26/2009 | WO2009038411A2 Beta-secretase inhibiting compounds having oxo-dihydro-pyrazole moiety |
| 03/26/2009 | WO2009037244A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 03/26/2009 | US20090082564 Ink jet dye design |
| 03/26/2009 | US20090082396 5-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonists |
| 03/26/2009 | US20090082395 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082372 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols |
| 03/26/2009 | US20090082350 Soluble epoxide hydrolase inhibitors |
| 03/26/2009 | US20090082348 Indazole derivatives |
| 03/26/2009 | US20090081123 Pharmaceutical compounds |
| 03/26/2009 | CA2698527A1 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1718624B1 Benzamide derivatives and their use as glucokinase activating agents |
| 03/25/2009 | CN101395157A Pyrrazole derivatives as sigma receptors antagonists |
| 03/25/2009 | CN101395152A Sigma receptor compounds |
| 03/25/2009 | CN101395139A Sigma receptor compounds |
| 03/25/2009 | CN101395138A Sigma receptor inhibitors |
| 03/25/2009 | CN100471858C Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 03/24/2009 | US7507834 Cyclin dependent kinases (CDK2) inhibitors; 4-[5-(3-bromo-phenyl)-2H-pyrazol-3-ylamino]-benzenesulfonamide; cancer and hyperproliferative diseases, such as psoriasis |
| 03/24/2009 | US7507833 e.g. 5-(3-(2-(4-(1-hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; glaucoma or ocular hypertension |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507755 Inhibitors of cathepsin s |
| 03/24/2009 | CA2407805C Dimethylpyrazole-blocked isocyanate mixtures |
| 03/19/2009 | WO2009035951A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035949A2 Soluble epoxide hydrolase inhibitors |
| 03/19/2009 | WO2009035542A2 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/19/2009 | WO2008149379A3 Novel compounds |
| 03/19/2009 | WO2008005511A8 Novel inhibitors of hepatitis c virus replication |
| 03/19/2009 | US20090076254 Comprises nucleotide sequences coding g-protein coupled receptors for identifying modulators and diagnosis, treatment and prevention of neurodegenerative, psychological, and sleep disorders |
| 03/19/2009 | US20090076113 Biphenylcarboxamides for controlling micro-organisms |
| 03/19/2009 | US20090076112 Deuterium-enriched eltrombopag |
| 03/19/2009 | US20090076012 Modulation of pathogenicity |
| 03/19/2009 | US20090075986 Anti-inflammatory medicaments |
| 03/19/2009 | CA2699412A1 Insecticidal carbamates exhibiting species-selective inhibition of acetylcholinesterase (ache) |
| 03/19/2009 | CA2697752A1 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 03/18/2009 | EP2036894A1 Aurora inhibitor |
| 03/18/2009 | EP2036893A1 Abl KINASE INHIBITOR |
| 03/18/2009 | EP2036887A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 03/18/2009 | EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/18/2009 | EP2035391A1 Indazole derivatives for treating hsp90-induced diseases |
| 03/18/2009 | EP2035390A2 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 03/18/2009 | EP2035389A1 Therapeutic agents |
| 03/18/2009 | EP2035388A1 Therapeutic agents |
| 03/18/2009 | EP2035374A1 N- (l-alkyl-2- phenylethyl) -carboxamide derivatives and use thereof as fungicides |
| 03/18/2009 | EP2035370A2 Tetralin and indane derivatives and uses thereof |
| 03/18/2009 | EP2034993A2 Pyrazinones as cellular proliferation inhibitors |
| 03/18/2009 | EP1663987B1 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |